SlideShare a Scribd company logo
Thermography: a NovelThermography: a Novel
Approach for Identification ofApproach for Identification of
Vulnerable PlaquesVulnerable Plaques
Mohammad Madjid, MD,Mohammad Madjid, MD,
Ward Casscells, MD,Ward Casscells, MD,
James T. Willerson, MD,James T. Willerson, MD,
Morteza Naghavi, MDMorteza Naghavi, MD
Disclosure:Disclosure:
Volcano Therapeutics, Inc.Volcano Therapeutics, Inc.
Holy Grail of Cardiology
How can we identify vulnerable plaques?How can we identify vulnerable plaques?
Atherosclerosis:Atherosclerosis:
An inflammatory diseaseAn inflammatory disease
Cardinal Signs of InflammationCardinal Signs of Inflammation
PainPain
RednessRedness
HEATHEAT
SwellingSwelling
InflammationInflammation
HypothesisHypothesis
Vascular inflammation and plaqueVascular inflammation and plaque
vulnerability can be identified byvulnerability can be identified by
the heat released from activatedthe heat released from activated
macrophages in the plaque.macrophages in the plaque.
RationaleRationale
 Macrophages are metabolically very active withMacrophages are metabolically very active with
a high turn-over rate of total ATP content.a high turn-over rate of total ATP content.
Newsholme P.Newsholme P. Biochem JBiochem J. 1989;261:211-8. 1989;261:211-8
 This high metabolic rate can lead to increasedThis high metabolic rate can lead to increased
heat production in areas of macrophageheat production in areas of macrophage
accumulation while it cannot be observed inaccumulation while it cannot be observed in
areas of smooth muscle cell accumulation in theareas of smooth muscle cell accumulation in the
absence of inflammatory cell infiltration.absence of inflammatory cell infiltration.
Bjornheden T.Bjornheden T. ArteriosclerosisArteriosclerosis. 1987;7:238-47. 1987;7:238-47
Temperature heterogeneity over the surfaceTemperature heterogeneity over the surface
of an endartherectomized carotid plaqueof an endartherectomized carotid plaque
Casscells W et al. Lancet. 1996;347:1447-51
While macrophage/monocytes (with high metabolic rate) density wasWhile macrophage/monocytes (with high metabolic rate) density was
related to higher temperature, such a relation wasn’t seen with smoothrelated to higher temperature, such a relation wasn’t seen with smooth
muscle cell density (with less metabolic activity)muscle cell density (with less metabolic activity)
Inverse relation between temperatureInverse relation between temperature
difference and cap thicknessdifference and cap thickness
Infrared experiments showInfrared experiments show
temperature heterogeneitytemperature heterogeneity
Our dog model of atherosclerosis develops
marked lesions in its coronary arteries (left panel).
We observed significant temperature
heterogeneity along the coronary arteries of these
dogs using an infrared camera (right panel).
An infrared camera image shows
marked temperature
heterogeneity over the surface of
an atherosclerotic carotid plaque
Inverse correlation of pH and temperature (ºC) inInverse correlation of pH and temperature (ºC) in
endartherectomized human carotid artery plaquesendartherectomized human carotid artery plaques
Naghavi et al. Atherosclerosis, 2002, in press
In vivo StudiesIn vivo Studies
Thermosensor Basket CatheterThermosensor Basket Catheter
Basket CatheterBasket Catheter
Thermal Resolution 0.01 C
Thermal Accuracy 0.02 C
Size (2-4 F expandable)
 Spatial ResolutionSpatial Resolution 0.5 mm0.5 mm
 Sampling RateSampling Rate 5-25 per sec5-25 per sec
 Number of wall sensorsNumber of wall sensors 44
 Blood sensorBlood sensor 11
Dog Model of AtherosclerosisDog Model of Atherosclerosis
Femoral Artery
Atherosclerotic
With Temperature Heterogeneity
Carotid Artery
Non-Atherosclerotic
Without Temperature Heterogeneity
Higher absolute temperature as well as temperature heterogeneity in femoral
arteries of atherosclerotic dogs compared to their carotid arteries which are
free of disease.
P<0.05
Temperature heterogeneity inTemperature heterogeneity in
atherosclerotic lesions of Watabae rabbitsatherosclerotic lesions of Watabae rabbits
Temperature heterogeneity
In aortae of atherosclerotic mice
No temperature heterogeneity
In aortae of normal mice
Infrared angio-thermographyInfrared angio-thermography
cathetercatheter
Infrared angio-thermographyInfrared angio-thermography
cathetercatheter
 Thermal resolution of 0.01º CThermal resolution of 0.01º C
 Spatial resolution of 100 microns.Spatial resolution of 100 microns.
 Real-time image reconstruction softwareReal-time image reconstruction software
 1mm window1mm window
 Two-dimensional and virtual longitudinal color-Two-dimensional and virtual longitudinal color-
coded thermographic imagescoded thermographic images
 We have tested the catheter in our phantom modelWe have tested the catheter in our phantom model
simulating “hot plaques” with continuous flow ofsimulating “hot plaques” with continuous flow of
normal saline in a silicon tube with multiple hotnormal saline in a silicon tube with multiple hot
spotsspots
 In vivoIn vivo studies are under way to confirm our findingsstudies are under way to confirm our findings
fromfrom ex vivoex vivo studies.studies.
Human StudiesHuman Studies
Our findings have been confirmedOur findings have been confirmed
in clinical settings by the Hellenicin clinical settings by the Hellenic
group of Stefandis andgroup of Stefandis and
colleagues, and also in Belgiumcolleagues, and also in Belgium
and the Netherlands.and the Netherlands.
In vivoIn vivo thermal heterogeneity within humanthermal heterogeneity within human
atherosclerotic coronary arteriesatherosclerotic coronary arteries
Stefanadis et al. Circulation. 1999;99:1965-71
The risk of an adverse cardiac event in patients with highThe risk of an adverse cardiac event in patients with high
temperature difference is significantly higher than that intemperature difference is significantly higher than that in
ACS patients with low temperature differenceACS patients with low temperature difference
Stefanadis et al. J Am Coll Cardiol. 2001;37:1277-83Stefanadis et al. J Am Coll Cardiol. 2001;37:1277-83
Stefanadis et al. J Mol Cell Cardiol. 2000;32:43-52
Strong correlation between C-reactive protein (CRP) (and serum
amyloid A (SAA) ) and the temperature differences
Administration of atorvastatin in patients with coronary arteryAdministration of atorvastatin in patients with coronary artery
disease results in less heat production from the culprit lesion anddisease results in less heat production from the culprit lesion and
less temperature difference.less temperature difference.
Stefanadis et al. Eur Heart J (in press)
StatinsNo statin
Temperaturedifference
2.5
2.0
1.5
1.0
.5
0.0
-.5
P<0,001
 Toutozas et al reported correlation betweenToutozas et al reported correlation between
temperature and expansive remodeling andtemperature and expansive remodeling and
MMP-9 concentrationMMP-9 concentration
 Verheye et al showed that temperatureVerheye et al showed that temperature
heterogeneity was reduced after change fromheterogeneity was reduced after change from
high to low-cholesterol diet in rabbits.high to low-cholesterol diet in rabbits.
Toutouzas et al. Circulation. 2000;102:II-707;
Toutouzas et al. J Am Coll Cardiol. 2001;37:356A
Verheye et al. Circulation Supple Oct. 2001;
FutureFuture
CombinationCombination with anatomical imaging methodswith anatomical imaging methods
to yield additional functional information aboutto yield additional functional information about
the lesionthe lesion
FutureFuture
A combination ofA combination of
ultrasound andultrasound and
thermography couldthermography could
provide thermal, andprovide thermal, and
structural datastructural data
valuable for detectingvaluable for detecting
and determination ofand determination of
functional status offunctional status of
plaques.plaques.
IVUS or OCT + ThermographyIVUS or OCT + Thermography
ActivityActivity ThermographyThermography
Anatomy (shape)Anatomy (shape) IVUS - OCTIVUS - OCT
ElasticityElasticity ElastographyElastography
Chemical compositionChemical composition Integrated RFIntegrated RF
BackscatteringBackscattering
SpectroscopySpectroscopy
Conclusion:Conclusion:
 As cardiology enters into the arena of vulnerable plaqueAs cardiology enters into the arena of vulnerable plaque
and vulnerable patient, along with the other emergingand vulnerable patient, along with the other emerging
diagnostic techniques such as OCT, elastography, anddiagnostic techniques such as OCT, elastography, and
near infrared spectroscopy,near infrared spectroscopy, thermographythermography catheter iscatheter is
ready to enter into cat labs.ready to enter into cat labs.
 Clinical studies in 2002 and 2003 will shed light on howClinical studies in 2002 and 2003 will shed light on how
we can utilize these emerging technologies to improvewe can utilize these emerging technologies to improve
our ability for identifying patients at extreme risk ofour ability for identifying patients at extreme risk of
coronary event, namely vulnerable patients.coronary event, namely vulnerable patients.
 The ultimate solution must be sought in non-invasiveThe ultimate solution must be sought in non-invasive
techniques where by developing a proper combination oftechniques where by developing a proper combination of
novel serum markers and non-invasive imaging tools thenovel serum markers and non-invasive imaging tools the
world of cardiology would be ready toworld of cardiology would be ready to attack the long-attack the long-
standing dilemma of out-of-hospital sudden heart attackstanding dilemma of out-of-hospital sudden heart attack
and coronary death.and coronary death.
ThermaStar Catheter
Not cleared by
the FDA and not
available for
commercial sale.
Center for Vulnerable Plaque ResearchCenter for Vulnerable Plaque Research
Houston, TexasHouston, Texas
Khawar Gul, MDKhawar Gul, MD
Said Siadaty, MDSaid Siadaty, MD
Sameh Naguib, MDSameh Naguib, MD
Bujin Gu, PhDBujin Gu, PhD
Reji John, MDReji John, MD
Basit Malik, MDBasit Malik, MD
KC Courian, MDKC Courian, MD
Roxana Grausu, MDRoxana Grausu, MD
Mohammad Madjid, MD, Ward Casscells, MD, James T. Willerson, MD, Morteza Naghavi, MDMohammad Madjid, MD, Ward Casscells, MD, James T. Willerson, MD, Morteza Naghavi, MD

More Related Content

Viewers also liked

The entire poster presentation of vp symposium acc 2003
The entire poster presentation of vp symposium acc 2003The entire poster presentation of vp symposium acc 2003
The entire poster presentation of vp symposium acc 2003
Society for Heart Attack Prevention and Eradication
 
Es v2n16
Es v2n16Es v2n16
Ca cvpr dec12
Ca cvpr dec12Ca cvpr dec12
Transgenic cetp dahl salt sensitive (tg53) rat model
Transgenic cetp dahl salt sensitive (tg53) rat modelTransgenic cetp dahl salt sensitive (tg53) rat model
Transgenic cetp dahl salt sensitive (tg53) rat model
Society for Heart Attack Prevention and Eradication
 
Cell culture study
Cell culture studyCell culture study
Spio mri studies by dr naghavi - amersham oct 2003 - part2
Spio mri studies by dr naghavi - amersham oct 2003 - part2Spio mri studies by dr naghavi - amersham oct 2003 - part2
Spio mri studies by dr naghavi - amersham oct 2003 - part2
Society for Heart Attack Prevention and Eradication
 
Thermal hetrogeneity clinical syndrome 2
Thermal hetrogeneity   clinical syndrome 2Thermal hetrogeneity   clinical syndrome 2
Thermal hetrogeneity clinical syndrome 2
Society for Heart Attack Prevention and Eradication
 
Stephanes talk aeha
Stephanes talk aehaStephanes talk aeha
Berk
BerkBerk
Carotid atherosclerotic lesion models for mri endpoints insull
Carotid atherosclerotic lesion models for mri endpoints insullCarotid atherosclerotic lesion models for mri endpoints insull
Carotid atherosclerotic lesion models for mri endpoints insull
Society for Heart Attack Prevention and Eradication
 
Es v2n50
Es v2n50Es v2n50
Drnaghavi
DrnaghaviDrnaghavi
Cardiac petct ahmed tawakol
Cardiac petct ahmed tawakolCardiac petct ahmed tawakol
Contrast enhanced mri of the vp black or white
Contrast enhanced mri of the vp   black or whiteContrast enhanced mri of the vp   black or white
Contrast enhanced mri of the vp black or white
Society for Heart Attack Prevention and Eradication
 

Viewers also liked (14)

The entire poster presentation of vp symposium acc 2003
The entire poster presentation of vp symposium acc 2003The entire poster presentation of vp symposium acc 2003
The entire poster presentation of vp symposium acc 2003
 
Es v2n16
Es v2n16Es v2n16
Es v2n16
 
Ca cvpr dec12
Ca cvpr dec12Ca cvpr dec12
Ca cvpr dec12
 
Transgenic cetp dahl salt sensitive (tg53) rat model
Transgenic cetp dahl salt sensitive (tg53) rat modelTransgenic cetp dahl salt sensitive (tg53) rat model
Transgenic cetp dahl salt sensitive (tg53) rat model
 
Cell culture study
Cell culture studyCell culture study
Cell culture study
 
Spio mri studies by dr naghavi - amersham oct 2003 - part2
Spio mri studies by dr naghavi - amersham oct 2003 - part2Spio mri studies by dr naghavi - amersham oct 2003 - part2
Spio mri studies by dr naghavi - amersham oct 2003 - part2
 
Thermal hetrogeneity clinical syndrome 2
Thermal hetrogeneity   clinical syndrome 2Thermal hetrogeneity   clinical syndrome 2
Thermal hetrogeneity clinical syndrome 2
 
Stephanes talk aeha
Stephanes talk aehaStephanes talk aeha
Stephanes talk aeha
 
Berk
BerkBerk
Berk
 
Carotid atherosclerotic lesion models for mri endpoints insull
Carotid atherosclerotic lesion models for mri endpoints insullCarotid atherosclerotic lesion models for mri endpoints insull
Carotid atherosclerotic lesion models for mri endpoints insull
 
Es v2n50
Es v2n50Es v2n50
Es v2n50
 
Drnaghavi
DrnaghaviDrnaghavi
Drnaghavi
 
Cardiac petct ahmed tawakol
Cardiac petct ahmed tawakolCardiac petct ahmed tawakol
Cardiac petct ahmed tawakol
 
Contrast enhanced mri of the vp black or white
Contrast enhanced mri of the vp   black or whiteContrast enhanced mri of the vp   black or white
Contrast enhanced mri of the vp black or white
 

Similar to Thermographya novel approach for the identification of vp

067 the holy grail of cardiology
067 the holy grail of cardiology067 the holy grail of cardiology
067 the holy grail of cardiology
SHAPE Society
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
SHAPE Society
 
067 the holy grail of cardiology
067 the holy grail of cardiology067 the holy grail of cardiology
067 the holy grail of cardiology
Society for Heart Attack Prevention and Eradication
 
Esv2n42
Esv2n42Esv2n42
102 hot plaque
102 hot plaque102 hot plaque
102 hot plaque
102 hot plaque102 hot plaque
102 hot plaque
SHAPE Society
 
Esv2n13
Esv2n13Esv2n13
095 thermography idenitfying vulnerable plaques
095 thermography idenitfying vulnerable plaques095 thermography idenitfying vulnerable plaques
095 thermography idenitfying vulnerable plaques
SHAPE Society
 
095 thermography idenitfying vulnerable plaques
095 thermography idenitfying vulnerable plaques095 thermography idenitfying vulnerable plaques
095 thermography idenitfying vulnerable plaques
Society for Heart Attack Prevention and Eradication
 
MEDICAL THEMOGRAPHY (applications and possibilities)
MEDICAL THEMOGRAPHY (applications and possibilities)MEDICAL THEMOGRAPHY (applications and possibilities)
MEDICAL THEMOGRAPHY (applications and possibilities)
slymartins
 
New insights into vulnerable plaque
New insights into vulnerable plaqueNew insights into vulnerable plaque
New insights into vulnerable plaque
Society for Heart Attack Prevention and Eradication
 
New insight to vp plaque imaging cvpr
New insight to vp plaque imaging  cvprNew insight to vp plaque imaging  cvpr
New insight to vp plaque imaging cvpr
Society for Heart Attack Prevention and Eradication
 
045 how can we identify the plaque at risk of rupture or thrombosis
045 how can we identify the plaque at risk of rupture or thrombosis045 how can we identify the plaque at risk of rupture or thrombosis
045 how can we identify the plaque at risk of rupture or thrombosis
Society for Heart Attack Prevention and Eradication
 
How can we identify the plaque at risk of rupture or thrombosis
How can we identify the plaque at risk of rupture or thrombosisHow can we identify the plaque at risk of rupture or thrombosis
How can we identify the plaque at risk of rupture or thrombosis
Society for Heart Attack Prevention and Eradication
 
045 how can we identify the plaque at risk of rupture or thrombosis
045 how can we identify the plaque at risk of rupture or thrombosis045 how can we identify the plaque at risk of rupture or thrombosis
045 how can we identify the plaque at risk of rupture or thrombosis
SHAPE Society
 
Stefanadis
StefanadisStefanadis
104 new advances in thermography
104 new advances in thermography104 new advances in thermography
104 new advances in thermography
SHAPE Society
 
104 new advances in thermography
104 new advances in thermography104 new advances in thermography
104 new advances in thermography
Society for Heart Attack Prevention and Eradication
 
New advances in thermography
New advances in thermographyNew advances in thermography

Similar to Thermographya novel approach for the identification of vp (20)

067 the holy grail of cardiology
067 the holy grail of cardiology067 the holy grail of cardiology
067 the holy grail of cardiology
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
 
067 the holy grail of cardiology
067 the holy grail of cardiology067 the holy grail of cardiology
067 the holy grail of cardiology
 
Esv2n42
Esv2n42Esv2n42
Esv2n42
 
102 hot plaque
102 hot plaque102 hot plaque
102 hot plaque
 
102 hot plaque
102 hot plaque102 hot plaque
102 hot plaque
 
Esv2n13
Esv2n13Esv2n13
Esv2n13
 
095 thermography idenitfying vulnerable plaques
095 thermography idenitfying vulnerable plaques095 thermography idenitfying vulnerable plaques
095 thermography idenitfying vulnerable plaques
 
095 thermography idenitfying vulnerable plaques
095 thermography idenitfying vulnerable plaques095 thermography idenitfying vulnerable plaques
095 thermography idenitfying vulnerable plaques
 
MEDICAL THEMOGRAPHY (applications and possibilities)
MEDICAL THEMOGRAPHY (applications and possibilities)MEDICAL THEMOGRAPHY (applications and possibilities)
MEDICAL THEMOGRAPHY (applications and possibilities)
 
New insights into vulnerable plaque
New insights into vulnerable plaqueNew insights into vulnerable plaque
New insights into vulnerable plaque
 
New insight to vp plaque imaging cvpr
New insight to vp plaque imaging  cvprNew insight to vp plaque imaging  cvpr
New insight to vp plaque imaging cvpr
 
045 how can we identify the plaque at risk of rupture or thrombosis
045 how can we identify the plaque at risk of rupture or thrombosis045 how can we identify the plaque at risk of rupture or thrombosis
045 how can we identify the plaque at risk of rupture or thrombosis
 
How can we identify the plaque at risk of rupture or thrombosis
How can we identify the plaque at risk of rupture or thrombosisHow can we identify the plaque at risk of rupture or thrombosis
How can we identify the plaque at risk of rupture or thrombosis
 
045 how can we identify the plaque at risk of rupture or thrombosis
045 how can we identify the plaque at risk of rupture or thrombosis045 how can we identify the plaque at risk of rupture or thrombosis
045 how can we identify the plaque at risk of rupture or thrombosis
 
Stefanadis
StefanadisStefanadis
Stefanadis
 
104 new advances in thermography
104 new advances in thermography104 new advances in thermography
104 new advances in thermography
 
104 new advances in thermography
104 new advances in thermography104 new advances in thermography
104 new advances in thermography
 
New advances in thermography
New advances in thermographyNew advances in thermography
New advances in thermography
 

More from Society for Heart Attack Prevention and Eradication

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
Society for Heart Attack Prevention and Eradication
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
Society for Heart Attack Prevention and Eradication
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
Society for Heart Attack Prevention and Eradication
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
Society for Heart Attack Prevention and Eradication
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
Society for Heart Attack Prevention and Eradication
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
Society for Heart Attack Prevention and Eradication
 
Vp watch2002
Vp watch2002Vp watch2002
Vp symposium31602
Vp symposium31602Vp symposium31602
Vpschoenhagen
VpschoenhagenVpschoenhagen

More from Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 

Recently uploaded

CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 

Recently uploaded (20)

CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 

Thermographya novel approach for the identification of vp

  • 1. Thermography: a NovelThermography: a Novel Approach for Identification ofApproach for Identification of Vulnerable PlaquesVulnerable Plaques Mohammad Madjid, MD,Mohammad Madjid, MD, Ward Casscells, MD,Ward Casscells, MD, James T. Willerson, MD,James T. Willerson, MD, Morteza Naghavi, MDMorteza Naghavi, MD
  • 3. Holy Grail of Cardiology How can we identify vulnerable plaques?How can we identify vulnerable plaques?
  • 5. Cardinal Signs of InflammationCardinal Signs of Inflammation PainPain RednessRedness HEATHEAT SwellingSwelling InflammationInflammation
  • 6. HypothesisHypothesis Vascular inflammation and plaqueVascular inflammation and plaque vulnerability can be identified byvulnerability can be identified by the heat released from activatedthe heat released from activated macrophages in the plaque.macrophages in the plaque.
  • 7. RationaleRationale  Macrophages are metabolically very active withMacrophages are metabolically very active with a high turn-over rate of total ATP content.a high turn-over rate of total ATP content. Newsholme P.Newsholme P. Biochem JBiochem J. 1989;261:211-8. 1989;261:211-8  This high metabolic rate can lead to increasedThis high metabolic rate can lead to increased heat production in areas of macrophageheat production in areas of macrophage accumulation while it cannot be observed inaccumulation while it cannot be observed in areas of smooth muscle cell accumulation in theareas of smooth muscle cell accumulation in the absence of inflammatory cell infiltration.absence of inflammatory cell infiltration. Bjornheden T.Bjornheden T. ArteriosclerosisArteriosclerosis. 1987;7:238-47. 1987;7:238-47
  • 8. Temperature heterogeneity over the surfaceTemperature heterogeneity over the surface of an endartherectomized carotid plaqueof an endartherectomized carotid plaque Casscells W et al. Lancet. 1996;347:1447-51
  • 9. While macrophage/monocytes (with high metabolic rate) density wasWhile macrophage/monocytes (with high metabolic rate) density was related to higher temperature, such a relation wasn’t seen with smoothrelated to higher temperature, such a relation wasn’t seen with smooth muscle cell density (with less metabolic activity)muscle cell density (with less metabolic activity)
  • 10. Inverse relation between temperatureInverse relation between temperature difference and cap thicknessdifference and cap thickness
  • 11. Infrared experiments showInfrared experiments show temperature heterogeneitytemperature heterogeneity Our dog model of atherosclerosis develops marked lesions in its coronary arteries (left panel). We observed significant temperature heterogeneity along the coronary arteries of these dogs using an infrared camera (right panel). An infrared camera image shows marked temperature heterogeneity over the surface of an atherosclerotic carotid plaque
  • 12. Inverse correlation of pH and temperature (ºC) inInverse correlation of pH and temperature (ºC) in endartherectomized human carotid artery plaquesendartherectomized human carotid artery plaques Naghavi et al. Atherosclerosis, 2002, in press
  • 13. In vivo StudiesIn vivo Studies
  • 15.
  • 16.
  • 17. Basket CatheterBasket Catheter Thermal Resolution 0.01 C Thermal Accuracy 0.02 C Size (2-4 F expandable)  Spatial ResolutionSpatial Resolution 0.5 mm0.5 mm  Sampling RateSampling Rate 5-25 per sec5-25 per sec  Number of wall sensorsNumber of wall sensors 44  Blood sensorBlood sensor 11
  • 18. Dog Model of AtherosclerosisDog Model of Atherosclerosis Femoral Artery Atherosclerotic With Temperature Heterogeneity Carotid Artery Non-Atherosclerotic Without Temperature Heterogeneity
  • 19. Higher absolute temperature as well as temperature heterogeneity in femoral arteries of atherosclerotic dogs compared to their carotid arteries which are free of disease. P<0.05
  • 20. Temperature heterogeneity inTemperature heterogeneity in atherosclerotic lesions of Watabae rabbitsatherosclerotic lesions of Watabae rabbits Temperature heterogeneity In aortae of atherosclerotic mice No temperature heterogeneity In aortae of normal mice
  • 22. Infrared angio-thermographyInfrared angio-thermography cathetercatheter  Thermal resolution of 0.01º CThermal resolution of 0.01º C  Spatial resolution of 100 microns.Spatial resolution of 100 microns.  Real-time image reconstruction softwareReal-time image reconstruction software  1mm window1mm window  Two-dimensional and virtual longitudinal color-Two-dimensional and virtual longitudinal color- coded thermographic imagescoded thermographic images  We have tested the catheter in our phantom modelWe have tested the catheter in our phantom model simulating “hot plaques” with continuous flow ofsimulating “hot plaques” with continuous flow of normal saline in a silicon tube with multiple hotnormal saline in a silicon tube with multiple hot spotsspots  In vivoIn vivo studies are under way to confirm our findingsstudies are under way to confirm our findings fromfrom ex vivoex vivo studies.studies.
  • 23. Human StudiesHuman Studies Our findings have been confirmedOur findings have been confirmed in clinical settings by the Hellenicin clinical settings by the Hellenic group of Stefandis andgroup of Stefandis and colleagues, and also in Belgiumcolleagues, and also in Belgium and the Netherlands.and the Netherlands.
  • 24. In vivoIn vivo thermal heterogeneity within humanthermal heterogeneity within human atherosclerotic coronary arteriesatherosclerotic coronary arteries Stefanadis et al. Circulation. 1999;99:1965-71
  • 25. The risk of an adverse cardiac event in patients with highThe risk of an adverse cardiac event in patients with high temperature difference is significantly higher than that intemperature difference is significantly higher than that in ACS patients with low temperature differenceACS patients with low temperature difference Stefanadis et al. J Am Coll Cardiol. 2001;37:1277-83Stefanadis et al. J Am Coll Cardiol. 2001;37:1277-83
  • 26. Stefanadis et al. J Mol Cell Cardiol. 2000;32:43-52 Strong correlation between C-reactive protein (CRP) (and serum amyloid A (SAA) ) and the temperature differences
  • 27. Administration of atorvastatin in patients with coronary arteryAdministration of atorvastatin in patients with coronary artery disease results in less heat production from the culprit lesion anddisease results in less heat production from the culprit lesion and less temperature difference.less temperature difference. Stefanadis et al. Eur Heart J (in press) StatinsNo statin Temperaturedifference 2.5 2.0 1.5 1.0 .5 0.0 -.5 P<0,001
  • 28.  Toutozas et al reported correlation betweenToutozas et al reported correlation between temperature and expansive remodeling andtemperature and expansive remodeling and MMP-9 concentrationMMP-9 concentration  Verheye et al showed that temperatureVerheye et al showed that temperature heterogeneity was reduced after change fromheterogeneity was reduced after change from high to low-cholesterol diet in rabbits.high to low-cholesterol diet in rabbits. Toutouzas et al. Circulation. 2000;102:II-707; Toutouzas et al. J Am Coll Cardiol. 2001;37:356A Verheye et al. Circulation Supple Oct. 2001;
  • 29. FutureFuture CombinationCombination with anatomical imaging methodswith anatomical imaging methods to yield additional functional information aboutto yield additional functional information about the lesionthe lesion
  • 30.
  • 31. FutureFuture A combination ofA combination of ultrasound andultrasound and thermography couldthermography could provide thermal, andprovide thermal, and structural datastructural data valuable for detectingvaluable for detecting and determination ofand determination of functional status offunctional status of plaques.plaques.
  • 32. IVUS or OCT + ThermographyIVUS or OCT + Thermography ActivityActivity ThermographyThermography Anatomy (shape)Anatomy (shape) IVUS - OCTIVUS - OCT ElasticityElasticity ElastographyElastography Chemical compositionChemical composition Integrated RFIntegrated RF BackscatteringBackscattering SpectroscopySpectroscopy
  • 33. Conclusion:Conclusion:  As cardiology enters into the arena of vulnerable plaqueAs cardiology enters into the arena of vulnerable plaque and vulnerable patient, along with the other emergingand vulnerable patient, along with the other emerging diagnostic techniques such as OCT, elastography, anddiagnostic techniques such as OCT, elastography, and near infrared spectroscopy,near infrared spectroscopy, thermographythermography catheter iscatheter is ready to enter into cat labs.ready to enter into cat labs.  Clinical studies in 2002 and 2003 will shed light on howClinical studies in 2002 and 2003 will shed light on how we can utilize these emerging technologies to improvewe can utilize these emerging technologies to improve our ability for identifying patients at extreme risk ofour ability for identifying patients at extreme risk of coronary event, namely vulnerable patients.coronary event, namely vulnerable patients.  The ultimate solution must be sought in non-invasiveThe ultimate solution must be sought in non-invasive techniques where by developing a proper combination oftechniques where by developing a proper combination of novel serum markers and non-invasive imaging tools thenovel serum markers and non-invasive imaging tools the world of cardiology would be ready toworld of cardiology would be ready to attack the long-attack the long- standing dilemma of out-of-hospital sudden heart attackstanding dilemma of out-of-hospital sudden heart attack and coronary death.and coronary death.
  • 34. ThermaStar Catheter Not cleared by the FDA and not available for commercial sale.
  • 35. Center for Vulnerable Plaque ResearchCenter for Vulnerable Plaque Research Houston, TexasHouston, Texas Khawar Gul, MDKhawar Gul, MD Said Siadaty, MDSaid Siadaty, MD Sameh Naguib, MDSameh Naguib, MD Bujin Gu, PhDBujin Gu, PhD Reji John, MDReji John, MD Basit Malik, MDBasit Malik, MD KC Courian, MDKC Courian, MD Roxana Grausu, MDRoxana Grausu, MD Mohammad Madjid, MD, Ward Casscells, MD, James T. Willerson, MD, Morteza Naghavi, MDMohammad Madjid, MD, Ward Casscells, MD, James T. Willerson, MD, Morteza Naghavi, MD